lenvatinib
Ligand Summary
a receptor tyrosine kinase (RTK) inhibitor that inhibits the kinase activities of vascular endothelial growth factor (VEGF) receptors VEGFR1 (FLT1), VEGFR2 (KDR), and VEGFR3 (FLT4)
UNII: EE083865G2
PubChem: 9823820
Guide to Pharmacology: 7426
ChEMBL: CHEMBL1289601
DrugCentral: 4942
LyCHI: U3UTLYD2YFNQ
Target Activities
29 Activities
Items per page:
10
1 – 10 of 29
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) | ||
|---|---|---|---|---|---|---|
IC50 | ||||||
IC50 | ||||||
IC50 | ||||||
IC50 | ||||||
IC50 | ||||||
IC50 | ||||||
IC50 | ||||||
IC50 | ||||||
IC50 | ||||||
IC50 | ||||||